$VTAK
Catheter Precision, Inc.

2019 Q1 Form 10-Q Financial Statement

#000156459019018937 Filed on May 14, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q1 2017 Q4
Revenue $1.748M $969.0K
YoY Change 80.39%
Cost Of Revenue $1.942M $736.0K
YoY Change 163.86%
Gross Profit -$194.0K $233.0K
YoY Change -183.26%
Gross Profit Margin -11.1% 24.05%
Selling, General & Admin $13.23M $2.639M
YoY Change 401.29%
% of Gross Profit 1132.62%
Research & Development $1.531M $286.0K
YoY Change 435.31%
% of Gross Profit 122.75%
Depreciation & Amortization $303.0K $96.00K $70.00K
YoY Change 215.63%
% of Gross Profit 41.2%
Operating Expenses $14.76M $2.925M
YoY Change 404.62%
Operating Profit -$14.95M -$2.692M
YoY Change 455.5%
Interest Expense $48.00K $1.000K
YoY Change 4700.0%
% of Operating Profit
Other Income/Expense, Net $280.0K -$1.000K
YoY Change -28100.0%
Pretax Income -$14.67M -$2.693M
YoY Change 444.89%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$14.67M -$2.693M
YoY Change 444.89%
Net Earnings / Revenue -839.47% -277.92%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.156M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 Q1 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $55.13M
YoY Change
Cash & Equivalents $55.13M $7.083M $8.237M
Short-Term Investments
Other Short-Term Assets $1.815M
YoY Change
Inventory $2.217M $1.196M
Prepaid Expenses
Receivables $1.292M $517.0K
Other Receivables $0.00
Total Short-Term Assets $60.45M $10.04M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $8.614M $1.159M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $213.0K $68.00K
YoY Change
Total Long-Term Assets $8.827M $1.227M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $60.45M $10.04M
Total Long-Term Assets $8.827M $1.227M
Total Assets $69.28M $11.27M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.411M $426.0K
YoY Change
Accrued Expenses $1.353M $324.0K
YoY Change
Deferred Revenue $1.954M $1.714M
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $367.0K
YoY Change
Total Short-Term Liabilities $5.085M $2.633M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $594.0K
YoY Change
Other Long-Term Liabilities $3.804M $81.00K
YoY Change
Total Long-Term Liabilities $4.398M $81.00K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.085M $2.633M
Total Long-Term Liabilities $4.398M $81.00K
Total Liabilities $9.483M $18.88M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$74.87M -$29.39M
YoY Change
Common Stock $134.7M $21.77M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $59.80M -$8.907M -$7.615M
YoY Change
Total Liabilities & Shareholders Equity $69.28M $11.27M
YoY Change

Cashflow Statement

Concept 2019 Q1 2018 Q1 2017 Q4
OPERATING ACTIVITIES
Net Income -$14.67M -$2.693M
YoY Change 444.89%
Depreciation, Depletion And Amortization $303.0K $96.00K $70.00K
YoY Change 215.63%
Cash From Operating Activities -$8.944M -$2.425M -$1.500M
YoY Change 268.82%
INVESTING ACTIVITIES
Capital Expenditures $165.0K $120.0K -$270.0K
YoY Change 37.5%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$165.0K -$120.0K -$270.0K
YoY Change 37.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.401M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -77.00K 1.391M 9.050M
YoY Change -105.54%
NET CHANGE
Cash From Operating Activities -8.944M -2.425M -1.500M
Cash From Investing Activities -165.0K -120.0K -270.0K
Cash From Financing Activities -77.00K 1.391M 9.050M
Net Change In Cash -9.186M -1.154M 7.280M
YoY Change 696.01%
FREE CASH FLOW
Cash From Operating Activities -$8.944M -$2.425M -$1.500M
Capital Expenditures $165.0K $120.0K -$270.0K
Free Cash Flow -$9.109M -$2.545M -$1.230M
YoY Change 257.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2693000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3084000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
45000
CY2018Q4 us-gaap Assets
Assets
74035000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1125000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2809000
CY2019Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1954000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1723000
CY2018Q4 rmed Equipment Financing Obligations Current
EquipmentFinancingObligationsCurrent
293000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
292000
CY2019Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
943000
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
767000
CY2018Q4 rmed Equipment Financing Obligations Noncurrent
EquipmentFinancingObligationsNoncurrent
557000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2861000
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
1000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
134670000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
126925000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-74874000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-60221000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
59797000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
66705000
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69280000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74035000
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12836970
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12689251
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12836970
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12689251
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1748000
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
969000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1942000
CY2018Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
736000
CY2019Q1 us-gaap Gross Profit
GrossProfit
-194000
CY2018Q1 us-gaap Gross Profit
GrossProfit
233000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13229000
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2639000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1531000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
286000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
14760000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
2925000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-14954000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2692000
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
328000
CY2019Q1 us-gaap Interest Expense
InterestExpense
48000
CY2018Q1 us-gaap Interest Expense
InterestExpense
1000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
280000
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14674000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-14674000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-2693000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.16
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12693000
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7938000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-14674000
CY2018Q1 us-gaap Profit Loss
ProfitLoss
-2693000
CY2019Q1 us-gaap Depreciation
Depreciation
303000
CY2018Q1 us-gaap Depreciation
Depreciation
96000
CY2019Q1 rmed Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
81000
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
24000
CY2018Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
88000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7745000
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
524000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4000
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
50000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
843000
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
386000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
107000
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
119000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
286000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
173000
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1748000
CY2018Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
51000
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
53000
CY2018Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-81000
CY2019Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-68000
CY2018Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-28000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8944000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2425000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
165000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
120000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-165000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-120000
CY2018Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1401000
CY2019Q1 rmed Payments On Equipment Financing
PaymentsOnEquipmentFinancing
77000
CY2018Q1 rmed Payments On Equipment Financing
PaymentsOnEquipmentFinancing
10000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-77000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1391000
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-9186000
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1154000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8237000
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7083000
CY2019Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
188000
CY2019Q1 rmed Transfer From Inventories To Property And Equipment For Demonstration Lasers Lasers And Lasers Placed With Customers
TransferFromInventoriesToPropertyAndEquipmentForDemonstrationLasersLasersAndLasersPlacedWithCustomers
723000
CY2018Q1 rmed Transfer From Inventories To Property And Equipment For Demonstration Lasers Lasers And Lasers Placed With Customers
TransferFromInventoriesToPropertyAndEquipmentForDemonstrationLasersLasersAndLasersPlacedWithCustomers
668000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
13000
CY2018Q1 us-gaap Interest Paid Net
InterestPaidNet
1000
CY2019Q1 us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
21000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7745000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-7615000
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1401000
CY2019Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">Use of estimates<font style="font-weight:normal;font-style:normal;">&#8212; The </font><font style="color:#000000;font-weight:normal;font-style:normal;">financial statements of the Company have been prepared by management in accordance with accounting principles generally accepted in the United States of America. </font><font style="font-weight:normal;font-style:normal;">The preparation of the financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and reported disclosures of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. The Company&#8217;s financial statements are based upon a number of estimates, including but not limited to, allowance for doubtful accounts, reserves for warranty costs, fair value of stock option awards granted and revenue recognition for multiple performance obligations.</font></p>
CY2019Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.07
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y
CY2019Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
300000
CY2018Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
100000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3200000
CY2019Q1 rmed Operating Lease Number Of Leases
OperatingLeaseNumberOfLeases
2
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
528000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
432000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
445000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1918000
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2019Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2800000
CY2019Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
600000
CY2019Q1 rmed Revenue Remaining Service Period To Recognize Deferred Revenue
RevenueRemainingServicePeriodToRecognizeDeferredRevenue
2024
CY2019Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
400000
CY2019Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
300000
CY2019Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
200000
CY2018Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
100000
CY2019Q1 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets1
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1
21000
CY2019Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
1992000
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1333000
CY2019Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
94000
CY2018Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
88000
CY2019Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
131000
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
676000
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7127000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6070000
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1597000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1313000
CY2019Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
574000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1734000
CY2019Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
193000
CY2018Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
112000
CY2019Q1 rmed Accrued Services Current
AccruedServicesCurrent
294000
CY2018Q4 rmed Accrued Services Current
AccruedServicesCurrent
963000
CY2017Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
87000
CY2019Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
273000
CY2018 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
287000
CY2019Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
192000
CY2018 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
262000
CY2019Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
100000
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
100000
CY2018Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
100000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
375000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
514000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
528000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
432000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
445000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1918000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4212000
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1059000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3153000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
500000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
514000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
4337000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7229000
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
448000
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y1M6D
CY2019Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2019Q1 us-gaap Revenues
Revenues
1748000
CY2018Q1 us-gaap Revenues
Revenues
969000
CY2019Q1 us-gaap Cost Of Revenue
CostOfRevenue
1942000
CY2018Q1 us-gaap Cost Of Revenue
CostOfRevenue
736000

Files In Submission

Name View Source Status
0001564590-19-018937-index-headers.html Edgar Link pending
0001564590-19-018937-index.html Edgar Link pending
0001564590-19-018937.txt Edgar Link pending
0001564590-19-018937-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gwczldxhgvln000001.jpg Edgar Link pending
gwczldxhgvln000002.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rmed-10q_20190331.htm Edgar Link pending
rmed-20190331.xml Edgar Link completed
rmed-20190331.xsd Edgar Link pending
rmed-20190331_cal.xml Edgar Link unprocessable
rmed-20190331_def.xml Edgar Link unprocessable
rmed-20190331_lab.xml Edgar Link unprocessable
rmed-20190331_pre.xml Edgar Link unprocessable
rmed-ex101_383.htm Edgar Link pending
rmed-ex311_313.htm Edgar Link pending
rmed-ex312_312.htm Edgar Link pending
rmed-ex321_311.htm Edgar Link pending
rmed-ex322_310.htm Edgar Link pending
Show.js Edgar Link pending